Suppr超能文献

法布里病中α-半乳糖苷酶A基因剪接位点突变的分析。

Analysis of splice-site mutations of the alpha-galactosidase A gene in Fabry disease.

作者信息

Lai L-W, Whitehair O, Wu M-J, O'Meara M, Lien Y-H H

机构信息

Department of Medicine, University of Arizona Health Sciences Center, Tucson, Arizona 85724, USA.

出版信息

Clin Genet. 2003 Jun;63(6):476-82. doi: 10.1034/j.1399-0004.2003.00077.x.

Abstract

Fabry disease is an X-linked disease caused by a defective lysosomal enzyme, alpha-galactosidase A, and characterized by skin lesions and multiorgan involvement, including kidney, heart, and the central nervous system. Currently more than 200 genotypes have been identified, including several aberrant splicing. However, most of the mutation analyses were performed using genomic sequencing only, and therefore some of the splicing mutations were misclassified as missense mutations. In order to predict the splicing event caused by each mutation, we conducted a literature search for all published mutations located near the splice sites, including exonic point mutations, and performed a splice-site score (SSS) analysis. The literature search identified 13 donor-site mutations, including four exonic mutations (S65T, D183S, K213N, and M267I), located at the end of exons 1, 3, 4, and 5, respectively, six acceptor-site mutations, and one new exon creation. All mutated splice sites, except for the one associated with the new exon creation, had a lower SSS than their respective natural sites. Cryptic or newly created sites were identified with SSS from 0.09 to 1.0. The predictions, based on SSS analysis, are in agreement with all six mutations with known cDNA sequence from the literature, including five mutations with exon skipping and one mutation with creation of a new acceptor site. For the S65T genotype, we performed reverse transcription-polymerase chain reaction (RT-PCR) analysis using RNA isolated from the whole-blood sample. We verified that a weak cryptic site (SSS = 0.09) 14 nucleotides downstream was activated and resulted in an insertion of 14 bp and a frameshift stop at codon 106. This change is more consistent with the clinical presentation of the patient, the classical Fabry disease, than the amino acid substitution (S65T), which does not affect the enzyme function. In conclusion, the SSS analysis is very useful for predicting splicing events and genotype/phenotype correlation in Fabry disease. As different mechanisms may be involved in pre-mRNA splicing, it is important to obtain cDNA sequencing for molecular diagnosis.

摘要

法布里病是一种X连锁疾病,由溶酶体酶α-半乳糖苷酶A缺陷引起,其特征为皮肤病变和多器官受累,包括肾脏、心脏和中枢神经系统。目前已鉴定出200多种基因型,包括几种异常剪接。然而,大多数突变分析仅使用基因组测序进行,因此一些剪接突变被错误分类为错义突变。为了预测每个突变引起的剪接事件,我们对所有位于剪接位点附近的已发表突变进行了文献检索,包括外显子点突变,并进行了剪接位点评分(SSS)分析。文献检索确定了13个供体位点突变,包括4个外显子突变(S65T、D183S、K213N和M267I),分别位于外显子1、3、4和5的末端,6个受体位点突变,以及1个新外显子的产生。除了与新外显子产生相关的那个突变剪接位点外,所有突变的剪接位点的SSS均低于其各自的天然位点。通过SSS鉴定出隐匿或新产生的位点,其分值为0.09至1.0。基于SSS分析的预测与文献中所有六个具有已知cDNA序列的突变一致,包括五个外显子跳跃突变和一个新受体位点产生的突变。对于S65T基因型,我们使用从全血样本中分离的RNA进行了逆转录-聚合酶链反应(RT-PCR)分析。我们证实,下游14个核苷酸处一个弱隐匿位点(SSS = 0.09)被激活,导致插入14个碱基对,并在密码子106处发生移码终止。这种变化比不影响酶功能的氨基酸替代(S65T)更符合患者(典型法布里病)的临床表现。总之,SSS分析对于预测法布里病的剪接事件和基因型/表型相关性非常有用。由于前体mRNA剪接可能涉及不同机制,因此获得cDNA测序以进行分子诊断很重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验